FF
PTCT icon

FourThought Financial’s PTC Therapeutics PTCT Stock Holding History

FourThought Financial’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$85K Hold
1,700
– – 0.01% 472
2022
Q2 		$68K Buy
1,700
+165
+11% +$5.79K 0.01% 526
2022
Q1 		$57K Buy
1,535
+197
+15% +$7.59K 0.01% 623
2021
Q4 		$53K Sell
1,338
-71
-5% -$2.72K 0.01% 644
2021
Q3 		$52K Buy
1,409
+17
+1% +$698 0.01% 683
2021
Q2 		$58K Sell
1,392
-23
-2% -$986 0.01% 663
2021
Q1 		$67K Sell
1,415
-103
-7% -$6.12K 0.01% 609
2020
Q4 		$92K Buy
+1,518
New +$89.5K 0.01% 502

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

FourThought Financial's PTCT Position: Q3 2022 in Review

FourThought Financial held its PTC Therapeutics (PTCT) position steady in Q3 2022 at 1,700 shares worth $85K. The position accounts for 0.01% of the portfolio, ranked #472.

FourThought Financial first reported a position in PTCT in Q4 2020 and has held it in 8 quarters since. The position peaked at $92K in Q4 2020. 213 funds tracked by Wall St. Rank hold PTCT as of Q3 2022.

  • FourThought Financial held 1,700 shares of PTC Therapeutics worth $85K as of Q3 2022.
  • FourThought Financial left its PTC Therapeutics share count unchanged in Q3 2022.
  • PTC Therapeutics made up 0.01% of FourThought Financial's portfolio in Q3 2022, its #472 holding.
  • FourThought Financial first reported a position in PTC Therapeutics in Q4 2020 and has held it in 8 quarters since.
  • FourThought Financial's PTC Therapeutics position peaked at $92K in Q4 2020.
  • 213 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.